标题
Delivery routes matter: Safety and efficacy of intratumoral immunotherapy
作者
关键词
Immunotherapy, Cancer, Intratumoral
出版物
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
Volume 1875, Issue 2, Pages 188526
出版商
Elsevier BV
发表日期
2021-02-21
DOI
10.1016/j.bbcan.2021.188526
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Intratumoral immunotherapy for early stage solid tumors
- (2020) Wan Xing Hong et al. CLINICAL CANCER RESEARCH
- Safe eradication of large established tumors using neovasculature‐targeted tumor necrosis factor‐based therapies
- (2020) Leander Huyghe et al. EMBO Molecular Medicine
- Intratumor injection of CCL21-coupled vault nanoparticles is associated with reduction in tumor volume in an in vivo model of glioma
- (2020) Brittany L. Voth et al. JOURNAL OF NEURO-ONCOLOGY
- Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
- (2019) Jana de Sostoa et al. Journal for ImmunoTherapy of Cancer
- Two roads for oncolytic immunotherapy development
- (2019) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- Antibody–Cytokine Fusions: Versatile Products for the Modulation of Anticancer Immunity
- (2019) Dario Neri Cancer Immunology Research
- Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs
- (2019) Susannah L. Hewitt et al. Science Translational Medicine
- Local delivery of OX40L, CD80, and CD86 mRNA kindles global anti-cancer immunity.
- (2019) Ole Audun Werner Haabeth et al. CANCER RESEARCH
- Induction of cell fusion/apoptosis in anaplastic thyroid carcinoma in orthotopic mouse model by urokinase‐specific oncolytic Sendai virus
- (2019) Yoshihiro Miyagawa et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- (2019) Jun Ishihara et al. Science Translational Medicine
- A toll-like receptor agonist mimicking microbial signal to generate tumor-suppressive macrophages
- (2019) Yanxian Feng et al. Nature Communications
- Coxsackievirus Type B3 is A Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma
- (2019) Haoyu Deng et al. Molecular Therapy-Oncolytics
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- (2019) Venkatesh Sivanandam et al. Molecular Therapy-Oncolytics
- OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
- (2019) Juan Deng et al. OncoTargets and Therapy
- Therapeutic strategies for the costimulatory molecule OX40 in T-cell mediated immunity
- (2019) Yu Fu et al. Acta Pharmaceutica Sinica B
- Repurposing the yellow fever vaccine for intratumoral immunotherapy
- (2019) Maria Angela Aznar et al. EMBO Molecular Medicine
- Engineering Newcastle disease virus as oncolytic vector for intratumoral delivery of immune checkpoint inhibitors and immunocytokines
- (2019) Gayathri Vijayakumar et al. JOURNAL OF VIROLOGY
- Intratumoral Immunotherapy—Update 2019
- (2019) Omid Hamid et al. ONCOLOGIST
- Toxicities associated with checkpoint inhibitors—an overview
- (2019) Laura Spiers et al. RHEUMATOLOGY
- Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
- (2019) Jenna H. Newman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion
- (2019) Nicholas C. DeVito et al. Frontiers in Immunology
- Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
- (2019) Victoria D. Turubanova et al. Journal for ImmunoTherapy of Cancer
- Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
- (2019) Oliver S. Thomas et al. Frontiers in Bioengineering and Biotechnology
- Necroptosis: a regulated inflammatory mode of cell death
- (2018) Yogesh K. Dhuriya et al. Journal of Neuroinflammation
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Complex role of NK cells in regulation of oncolytic virus–bortezomib therapy
- (2018) Yangjin Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced mRNA delivery into lymphocytes enabled by lipid-varied libraries of charge-altering releasable transporters
- (2018) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In situ vaccination: Harvesting low hanging fruit on the cancer immunotherapy tree
- (2018) Mee Rie Sheen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma
- (2018) Mark R. Albertini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice
- (2018) Ole A. W. Haabeth et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
- (2018) Lien Van Hoecke et al. Nature Communications
- Nanoparticle-Conjugate TLR7/8 Agonist Localized Immunotherapy Provokes Safe Antitumoral Responses
- (2018) Lutz Nuhn et al. ADVANCED MATERIALS
- 42PA phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) in combination with ipilimumab (IPI) and avelumab (AVE) plus intravenous low-dose nivolumab (NIVO) in patients with advanced solid tumors
- (2018) J K Schwarze et al. ANNALS OF ONCOLOGY
- Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
- (2018) A Marabelle et al. ANNALS OF ONCOLOGY
- Administration of Dendritic Cells and Anti-PD-1 Antibody Converts X-ray Irradiated Tumors Into Effective In situ Vaccines
- (2018) Yuzi Wang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Immunomodulation of the Tumor Microenvironment: Turn Foe Into Friend
- (2018) Hanne Locy et al. Frontiers in Immunology
- Thermosensitive Gel–Based Formulation for Intratumoral Delivery of Toll-Like Receptor 7/8 Dual Agonist, MEDI9197
- (2017) Amir Fakhari et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Charge-altering releasable transporters (CARTs) for the delivery and release of mRNA in living animals
- (2017) Colin J. McKinlay et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer
- (2017) Julia Tchou et al. Cancer Immunology Research
- Indicators of responsiveness to immune checkpoint inhibitors
- (2017) Bradley D. Shields et al. Scientific Reports
- Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
- (2016) Robert H. I. Andtbacka et al. ANNALS OF SURGICAL ONCOLOGY
- Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
- (2016) Laura Q.M. Chow et al. CLINICAL CANCER RESEARCH
- Immunocytokines for cancer treatment: past, present and future
- (2016) Dario Neri et al. CURRENT OPINION IN IMMUNOLOGY
- TGF-β Signaling in Cancer
- (2016) Viqar Syed JOURNAL OF CELLULAR BIOCHEMISTRY
- Phase II Study of Autologous Monocyte-Derived mRNA Electroporated Dendritic Cells (TriMixDC-MEL) Plus Ipilimumab in Patients With Pretreated Advanced Melanoma
- (2016) Sofie Wilgenhof et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally
- (2016) M. Angela Aznar et al. JOURNAL OF IMMUNOLOGY
- GIFT4 fusokine converts leukemic B cells into immune helper cells
- (2016) Jiusheng Deng et al. Journal of Translational Medicine
- Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
- (2016) Tania Løve Aaes et al. Cell Reports
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- OX40, OX40L and Autoimmunity: a Comprehensive Review
- (2015) Gwilym J. Webb et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Cytokines
- (2015) Thulasi Ramani et al. INTERNATIONAL JOURNAL OF TOXICOLOGY
- Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines
- (2015) Mikhail O Durymanov et al. Theranostics
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
- (2015) Kevin Van der Jeught et al. Oncotarget
- Preclinical evaluation of IL2-based immunocytokines supports their use in combination with dacarbazine, paclitaxel and TNF-based immunotherapy
- (2014) Francesca Pretto et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Optimized dendritic cell-based immunotherapy for melanoma: the TriMix-formula
- (2014) Sandra Van Lint et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The ReNAissanCe of mRNA-based cancer therapy
- (2014) Sandra Van Lint et al. Expert Review of Vaccines
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease
- (2014) Edin J. Mifsud et al. Frontiers in Immunology
- A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
- (2013) S. Wilgenhof et al. ANNALS OF ONCOLOGY
- Many faces of DAMPs in cancer therapy
- (2013) O Krysko et al. Cell Death & Disease
- Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
- (2012) S. Van Lint et al. CANCER RESEARCH
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
- (2012) Liming Sun et al. CELL
- Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis
- (2012) J. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo
- (2011) C Cocco et al. LEUKEMIA
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors
- (2010) Elizabeth D. Thompson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Single-Step Antigen Loading and Activation of Dendritic Cells by mRNA Electroporation for the Purpose of Therapeutic Vaccination in Melanoma Patients
- (2009) A. Bonehill et al. CLINICAL CANCER RESEARCH
- The significance of OX40 and OX40L to T-cell biology and immune disease
- (2009) Michael Croft et al. IMMUNOLOGICAL REVIEWS
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now